Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Not Confirmed
Not Confirmed
05-09 December, 2025
Not Confirmed
Not Confirmed
06-10 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Industry Trade Show
Not Confirmed
05-09 December, 2025
Industry Trade Show
Not Confirmed
06-10 December, 2025
Digital content

26 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251126808476/en/Corstasis-Therapeutics-and-Cardiovascular-Logistics-Partner-to-Redefine-Outpatient-Heart-Failure-Care-with-ENBUMYST-Bumetanide-Nasal-Spray

25 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250924250761/en/Corstasis-Therapeutics-and-U.S.-Heart-and-Vascular-Collaboration-Will-Seek-to-Improve-Heart-Failure-Care-with-ENBUMYST-Bumetanide-Nasal-Spray

18 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-18/aptar-pharma-s-unidose-system-delivers-enbumyst-first-us-fda-approved-intranasal-diuretic

16 Sep 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/corstasis-scores-fda-nod-nasal-spray-treatment-which-it-says-carries-multi-billion-sales

11 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-11/corstasis-therapeutics-strenghtens-leadership-team-with-the-appointment-of-dr-amin-medjamia-as-vp-o

03 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250902731398/en/Corstasis-Therapeutics-Announces-Allowance-of-a-New-Patent-and-Development-Updates-for-Subcutaneous-Programs-RSQ-786-and-RSQ-789
ABOUT THIS PAGE